`
`Orange Boolc Approved Drug Products with Therapeutic Equivalence Evaluations
`
` ID]fi\ U.S. Food and Drug Administrat n
`
`_ Protecting and Promotin- Your Health
`
`FDA Home3 Drug Databases4 Orange Book5
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Search results from the "OB_Rx" table for query on "021196."
`
`Active Ingredient:
`Dosage Form;Route:
`Proprietary Name:
`Applicant:
`Strength:
`Application Number:
`Product Number:
`
`Approval Date:
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`SODIUM OXYBATE
`SOLUTION;ORAL
`XYREM
`JAZZ PHARMS
`500MG/ML
`N021196
`001
`
`Jul 17, 2002
`Yes
`RX
`
`Patent and Exclusivity Info for this product:View
`
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through April 2014
`Patent and Generic Drug Product Data Last Updated June 11, 2014
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2 3 4
`
`5
`
`6
`
`http://www.addthis.com/bookmark. php
`
`http://www.fda.gov/defau|t. htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`../default.cfm
`
`../default.cfm
`
`If you need help accessing information in different file formats, see Instructions for Downloading
`Note:
`Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website
`Policies
`
`US. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888—INFO-FDA (1-888—463-6332)
`Email FDA
`f' ‘
`thwart. ,V
`
`0 [3 iii L'tl
`
`http://vvaaccessdaiafdag ov/scripis/cder/ob/dots/obdeiai| .cfm?Appl_N o= 021196&TABLE1= OB_Rx
`
`1/2
`
`PAR1021
`
`IPR of US. Patent No. 7,668,730
`Page 1 of4
`
` PAR1021
`IPR of U.S. Patent No. 7,668,730
` Page 1 of 4
`
`
`
`6/12/2014
`
`Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations
`
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`fig US. Department of Health Bl. Human Services
`
`Links on this page:
`
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`2. http://www.addthis.com/bookma rk.php
`
`3 4
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default. htm
`
`5.
`
`6 .
`
`../defau|t.cfm
`
`../default.cfm
`
`http://MAM/ilacoessdatafda .g ov/scri pts/cder/ob/docs/obdetai | .cfm?App|_N 0: 021 196&TABLE1= OB_RX
`
`2/2
`
`PAR1021
`
`IPR of US. Patent No. 7,668,730
`Page 2 of4
`
` PAR1021
`IPR of U.S. Patent No. 7,668,730
` Page 2 of 4
`
`
`
`6/4/2014
`
`Orange Book Approved Drug Products with Therapeutic Eq uivalence Evaluations
`
` ID]a\ US. Food and Drug Administration
`
`'- _ Protecting and Promotin- Your Health
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Patent and Exclusivity Search Results from query on Appl No 021196 Product 001 in the OB_Rx list.
`
`Prod No
`
`Patent Data
`
`App. No
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`N021196
`
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`
`PatentNo
`6780889
`7262219
`7668730
`7765106
`7765107
`7851506
`7851506
`7895059
`8263650
`8263650
`8324275
`8324275
`8457988
`8589182
`8731963
`
`551:2:an
`Jul 4, 2020
`Jul 4, 2020
`Jun 16, 2024
`Jun 16, 2024
`Jun 16, 2024
`Dec 22, 2019
`Dec 22, 2019
`Dec 17, 2022
`Dec 22, 2019
`Dec 22, 2019
`Dec 22, 2019
`Dec 22, 2019
`Dec 17, 2022
`Dec 17, 2022
`Dec 17, 2022
`
`Exclusivity Data
`There is no unexpired exclusivity for this product.
`Additional information:
`
`“932??“
`
`Y
`Y
`
`Y
`Y
`
`”“821?“
`
`”2525556
`
`Refiifiid
`
`U - 1110
`U - 1069
`U - 1070
`U - 1101
`U - 1102
`U -1110
`U -1101
`U -1102
`U -1101
`U -1102
`U -1110
`U -1110
`U -1110
`
`1. Patents are published upon receipt by the Orange Book Stafi and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
`2. Patents listed priorto August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be
`flagged with respect to other claims which may apply.
`
`View a list of all patent use codes
`View a list of all exclusivity codes
`
`Return to Electronic Orange Book Home Page6
`FDA/Centerfor Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through May 2014
`Patent and Generic Drug Product Data Last Updated June 03, 2014
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`2 3 4
`
`. http://www.fda.gov/Drugs/lnformationOn Drugs/default.htm
`5.
`../default.cfm
`
`6 .
`
`../default.cfm
`
`Note: lfyou need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-lNFO—FDA (1-888-463-6332)
`
`http://iMM/vaccessdatafdag ov/scripts/cder/obldocs/patexclnew.cfm?Appl_No=021196&Product_No= 001 &ta bl e1 = OB_Rx
`
`1/2
`
`PAR1021
`
`IPR of US. Patent No. 7,668,730
`Page 3 of4
`
` PAR1021
`IPR of U.S. Patent No. 7,668,730
` Page 3 of 4
`
`
`
`6/4/2014
`Email FDA
`
`Orange Book Approved Drug Products with Therapeutic Eq uivalence Evaluations
`
`\
`
`I: I3 éi i".
`~
`92:.“
`“
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`f US. Department of Health 81 Human Services
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`. http://www.fda.gov/default.htm
`
`2 3 4
`
`. http://www.fda.gov/Drugs/lnformationOn Drugs/default.htm
`5.
`../defau|t.cfm
`
`6 .
`
`../defau|t.cfm
`
`http://MAMNaccessdatafdag ov/scripts/cder/obldocs/patexclnew.cfm?AppI_No=021196&Product_No= 001 &ta bl e1 = OB_RX
`
`2/2
`
`PAR1021
`
`IPR of US. Patent No. 7,668,730
`Page 4 of4
`
` PAR1021
`IPR of U.S. Patent No. 7,668,730
` Page 4 of 4
`
`